The SELECT trial, as noted earlier, went a step further it tested Wegovy in overweight/obese individuals with cardiovascular disease (but without diabetes) and found a 20% reduction in heart attacks, stroke, or CV death ( [67] )
An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions
By linking genomic variation, functional traits, and environmental context, we generate data that strengthen pathogen surveillance, support risk-based decision-making, and inform regulatory science
Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults
Six experimental diets were formulated, incorporating different concentrations of l-carnitine